- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/768 - Oncolytic viruses not provided for in groups
Patent holdings for IPC class A61K 35/768
Total number of patents in this class: 857
10-year publication summary
|
34
|
48
|
84
|
81
|
85
|
100
|
63
|
77
|
52
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deutsches Krebsforschungszentrum | 411 |
30 |
| Kalivir Immunotherapeutics, Inc. | 53 |
25 |
| Memorial Sloan-Kettering Cancer Center | 1991 |
22 |
| Transgene S.A. | 126 |
21 |
| Ruprecht-Karls-Universität Heidelberg | 246 |
18 |
| Guangzhou Virotech Pharmaceutical Co., Ltd. | 26 |
17 |
| Mayo Foundation for Medical Education and Research | 3336 |
16 |
| Duke University | 3158 |
16 |
| Arizona Board of Regents on behalf of Arizona State University | 2788 |
16 |
| Sillajen, Inc. | 48 |
16 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3254 |
16 |
| Bionoxx Inc. | 20 |
14 |
| Hangzhou Converd Co., Ltd. | 35 |
13 |
| National University Corporation Tottori University | 206 |
12 |
| Seneca Therapeutics, Inc. | 14 |
12 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 382 |
10 |
| Ottawa Hospital Research Institute | 112 |
10 |
| City of Hope | 1007 |
9 |
| Icahn School of Medicine at Mount Sinai | 992 |
9 |
| SillaJen Biotherapeutics, Inc. | 23 |
9 |
| Other owners | 546 |